ANEMIA
Clinical trials for ANEMIA explained in plain language.
Never miss a new study
Get alerted when new ANEMIA trials appear
Sign up with your email to follow new studies for ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to cut blood transfusions for rare bone marrow disorder
Disease control OngoingThis study tests if luspatercept can help people with certain types of MDS or MDS/MPN need fewer blood transfusions for anemia. Six adults with low- or intermediate-risk disease and a specific gene mutation are receiving the drug plus standard care. The goal is to see if they can…
Matched conditions: ANEMIA
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 17, 2026 01:19 UTC
-
New hope for anemia patients: drug may cut need for blood transfusions
Disease control OngoingThis study tests a drug called luspatercept in people with anemia from two conditions: myelodysplastic syndromes (MDS) or beta-thalassemia. Participants need regular red blood cell transfusions. The goal is to see if the drug can safely reduce the number of transfusions they need…
Matched conditions: ANEMIA
Phase: PHASE4 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 17, 2026 01:18 UTC
-
New hope for myelofibrosis patients with severe anemia
Disease control OngoingThis study tests a new drug (INCB000928) given alone or with another drug (ruxolitinib) in 84 people with myelofibrosis who have anemia. The goal is to find a safe dose that can raise red blood cell levels and reduce the need for blood transfusions. The study is in early phases (…
Matched conditions: ANEMIA
Phase: PHASE1, PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 17, 2026 01:18 UTC
-
Can a drug combo boost red blood cells in bone marrow disease patients?
Disease control OngoingThis study tests whether adding a second drug (epoetin alfa) to lenalidomide helps people with myelodysplastic syndrome (MDS) and anemia more than lenalidomide alone. About 247 adults with low- or intermediate-risk MDS and low red blood cell counts took part. The main goal was to…
Matched conditions: ANEMIA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 01:18 UTC
-
Blood substitute offers lifeline for patients who Can't get transfusions
Disease control NO_LONGER_AVAILABLEThis study provided an experimental blood substitute called HBOC-201 to adults with life-threatening anemia who could not receive standard blood transfusions. The treatment is made from purified cow hemoglobin and helps carry oxygen to tissues without needing blood type matching.…
Matched conditions: ANEMIA
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Promising prostate cancer trial pulled before it even started
Disease control TerminatedThis study was withdrawn before enrolling any participants. It planned to test a radioactive drug called 177Lu-PSMA-617 in men with advanced prostate cancer that had spread to the bone marrow and caused low blood cell counts. The goal was to see if the drug was safe and could hel…
Matched conditions: ANEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New targeted therapy challenges chemo for younger CLL patients
Disease control OngoingThis study tested whether a combination of ibrutinib (a targeted drug) and rituximab works better than standard chemotherapy (FCR) for younger patients with untreated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma. Over 500 participants were randomly assigned to…
Matched conditions: ANEMIA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Birth control showdown: which method boosts anemia better?
Disease control OngoingThis study looks at whether a hormonal IUS or birth control pills with iron better improve anemia in women with mild to moderate anemia who want contraception. About 405 women in Kenya will be followed for 12-18 months. The main goal is to see which method raises hemoglobin level…
Matched conditions: ANEMIA
Phase: NA • Sponsor: FHI 360 • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Could a daily pill stop HHT nosebleeds? new trial investigates.
Disease control OngoingThis study tests whether a low dose of the drug pazopanib, taken daily for 24 weeks, can reduce the severity and duration of nosebleeds in people with hereditary hemorrhagic telangiectasia (HHT). About 70 participants will receive either the active drug or a placebo. The research…
Matched conditions: ANEMIA
Phase: PHASE2, PHASE3 • Sponsor: Cure HHT • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New blood treatment aims to block zika during transfusions
Disease control OngoingThis study tests whether treating red blood cells with the INTERCEPT Blood System can safely reduce the risk of Zika virus transmission during transfusions. About 692 patients who need blood transfusions will receive either treated or standard red blood cells. The main goals are …
Matched conditions: ANEMIA
Phase: PHASE3 • Sponsor: Cerus Corporation • Aim: Disease control
Last updated Apr 26, 2026 19:35 UTC
-
Prenatal B12 boost may sharpen baby brains
Prevention OngoingThis study tests whether giving vitamin B12 supplements to pregnant women at risk of deficiency can improve their children's growth and brain development. About 800 pregnant women in Nepal will take either a daily B12 pill or a placebo from early pregnancy until 6 months after bi…
Matched conditions: ANEMIA
Phase: PHASE2, PHASE3 • Sponsor: Centre For International Health • Aim: Prevention
Last updated May 17, 2026 01:16 UTC
-
Could Salmon-Derived iron pills beat anemia?
Symptom relief OngoingThis study looks at how well a new iron supplement made from fish (SalmoFer®) is absorbed by the body and whether it causes stomach discomfort. It involves 61 women aged 21 to 42 with low iron or mild anemia. Researchers will measure iron levels in blood and track any digestive s…
Matched conditions: ANEMIA
Phase: NA • Sponsor: Nutraceuticals Research Institute • Aim: Symptom relief
Last updated May 13, 2026 16:02 UTC
-
Holistic stress study withdrawn before starting
Knowledge-focused TerminatedThis study aimed to see if holistic pastoral counseling could help people manage stress at work and in daily life. It was designed for unmarried Alaska Medicaid recipients aged 22 and older who had internet access and a Bible. However, the study was withdrawn before any participa…
Matched conditions: ANEMIA
Phase: NA • Sponsor: Goddess Zena I. Jones • Aim: Knowledge-focused
Last updated May 17, 2026 01:21 UTC
-
Uganda study tracks Kids' growth after family support program
Knowledge-focused OngoingThis study looks at how children (ages 0-9) in Ugandan communities are developing after their families took part in a program called Graduation to Resilience. Researchers will measure things like height, anemia, thinking skills, and school readiness. No new treatments are given—t…
Matched conditions: ANEMIA
Phase: NA • Sponsor: Innovations for Poverty Action • Aim: Knowledge-focused
Last updated May 17, 2026 01:19 UTC
-
1,300 teens tracked to break cycle of malnutrition
Knowledge-focused OngoingThis study follows 1,304 healthy rural Indian children aged 8-10 to see how their growth, bone strength, and muscle health change over time. Researchers want to understand how nutrition and family health history affect these changes. The goal is to find ways to improve health for…
Matched conditions: ANEMIA
Sponsor: Hirabai Cowasji Jehangir Medical Research Institute • Aim: Knowledge-focused
Last updated May 17, 2026 01:17 UTC
-
Vitamin d and fish oil: a new hope against anemia in the elderly?
Knowledge-focused OngoingThis study looks at whether taking daily vitamin D or fish oil supplements can lower the chance of developing anemia in older adults. Researchers will track 2000 participants from a larger heart health study over 2 years, checking for new anemia cases and changes in blood protein…
Matched conditions: ANEMIA
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC
-
Can a tablet improve pregnancy care for thousands of women in south asia?
Knowledge-focused OngoingThis study tests a tablet-based decision support system called mIRA, designed to help frontline health workers in India and Nepal provide better antenatal care. The tool guides them to check for high blood pressure, diabetes, and anemia during routine visits. About 1,320 pregnant…
Matched conditions: ANEMIA
Phase: NA • Sponsor: Public Health Foundation of India • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
Tiny preemies, big gut mystery: can blood transfusions harm digestion?
Knowledge-focused OngoingThis study observes how anemia and red blood cell transfusions affect oxygen levels in the digestive tract of extremely low birth weight infants (≤1250 grams). Researchers will analyze blood, urine, and stool samples to find markers that may predict serious gut problems like necr…
Matched conditions: ANEMIA
Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 11, 2026 20:39 UTC
-
Heart failure drug may boost red blood cells and protect organs
Knowledge-focused OngoingThis study reviews medical records of 85 adults with chronic heart failure to see if SGLT2 inhibitors (a type of diabetes drug) improve red blood cell production and heart/kidney function over 12 months. Researchers compare those who started the drug to a similar group who did no…
Matched conditions: ANEMIA
Sponsor: University Medical Centre Ljubljana • Aim: Knowledge-focused
Last updated May 04, 2026 16:30 UTC